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Abstract 
Background: Numerous diseases have been related with free radicals overproduction 
and oxidative stress. Botanical preparations possess a multitude of bioactive properties, 
including antioxidant potential, which has been mainly related with the presence of 
phenolic compounds. However, the mechanisms of action of these phytochemicals, in 
vivo effects, bioavailability and bio-efficacy still need research. 
Scope and Approach: The present report aims to provide a critical review on the aspects 
related with the in vivo antioxidant activity of phenolic extracts and compounds from 
plant origin.  
Key findings: Biological functions beyond the human metabolism were discussed, 
comparing in vivo vs. in vitro studies, as also focusing the conditioning factors for 
phenolic compounds bioavailability and bio-efficacy. Furthermore, an upcoming 
perspective about the use of phytochemicals as life expectancy promoters and anti-aging 
factors in human individuals was provided. 
Conclusions: Overall, and despite all of those advances, the study of the biological 
potential of numerous natural matrices still remains a hot topic among the scientific 
community. In fact, the available knowledge about the responsible phytochemicals for 
the biological potential, their mechanisms of action, the establishment of therapeutic 
and prophylactic doses, and even the occurrence of biochemical inter-relations, is 
considerable scarce.  
 
 
Keywords: Aging-related diseases; Antioxidant activity; In vivo studies; Phenolic 
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 1. Introduction 
In the last years, oxidative stress-related diseases/disorders have gained a special 
attention. Metabolic, neurodegenerative, cardiovascular, mitochondrial diseases and 
even cancer, are among the most frequent (Chaturvedi & Beal, 2013; Halliwell, 2012; 
Singh, Sharad, & Kapur, 2004). Numerous studies have been investigating the 
underlying triggering factors, in order to understand the mechanisms of action of free 
radicals, as well as to discover effective substances towards preventing and even 
reversing the occurrence of oxidative damages (Espín, García-Conesa, & Tomás-
Barberán, 2007; Fernandez-Panchon, Villano, Troncoso, & Garcia-Parrilla, 2008).  
Antioxidants, both from natural and synthetic sources, have proved to be highly 
effective to control the magnitude of free radicals production, to prevent its undesirable 
effects, as well as to support the organism antioxidant and detoxifying mechanisms 
(Holst & Williamson, 2008; Kapravelou et al., 2015; Valko et al., 2007; Yeh & Yen, 
2006).  
Phenolic compounds have shown promising antioxidant properties, with its potential 
being directly related with the type of solvent used in the extraction, but also with plant 
origin, growing conditions, harvesting time, and storage conditions (Avello, Pastene, 
Bustos, Bittner, & Becerra, 2013; Taârit, Msaada, Hosni, & Marzouk, 2012; Trabelsi et 
al., 2012). The study of the antioxidant potential of phenolic extracts derived from plant 
species is one of the hot topics among the scientific community; however, in vitro 
studies are the most common (Dai & Mumper, 2010; Larrosa, García-Conesa, Espín, & 
Tomás-Barberán, 2010; Rubió, Motilva, & Romero, 2013). Nevertheless, these studies 
do not consider biochemical, metabolic and other physiological parameters 
(Devasagayam et al., 2004; Espín et al., 2007; Fernandez-Panchon et al., 2008). In vivo 
studies have been mainly performed in eukaryotic cells, mice, fishes, guinea-pigs and 
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rabbits, but studies involving human clinical trials remain scarce (Fernandez-Panchon et 
al., 2008; Goodman, Bostick, Kucuk, & Jones, 2011; Rubió et al., 2013). Several 
biological and physiological variables can be accessed and measured by those studies, 
including the metabolism of the tested matrices, as well as their bioavailability (Espín et 
al., 2007; Holst & Williamson, 2008).  
Not only natural but also synthetic antioxidants suffer numerous biochemical reactions 
along ingestion, digestion and absorption by the organisms. Therefore, and despite the 
current advances, the effective bioavailability of the different antioxidants is not clearly 
defined: while many of them are ingested on its active form, others need to be 
metabolized to be biologically active, or even become inactive; furthermore, the co-
ingestion of other nutrients, as also several endogenous factors, and the inter and intra-
individual variations, affect their bioavailability in relation to the ingested dose (Espín 
et al., 2007; Heim, Tagliaferro, & Bobilya, 2002; Holst & Williamson, 2008). This fact 
explains why some plant species and even isolated compounds do not evidence positive 
effect through in vitro studies, but a strong antioxidant potential is observed when in 
vivo studies are carried out, and vice-versa. 
In this sense, the objective of the present report was to review data related with in vivo 
antioxidant activity of phenolic extracts and compounds, highlighting parameters 
involved in their metabolism, bioavailability and capacity to prevent/avert aging-related 
diseases. 
 
2. Human nutrition: nutrients and phytochemicals 
2.1. Critical perspective 
Dietary practices play an important and unquestionable role at health level. Increasing 
evidences have shown that certain foods (currently known as functional foods) possess 
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numerous health benefits, being able not only to prevent a wide variety of human 
disorders, but also to revert and even block degenerative processes (Devasagayam et al., 
2004; Espín et al., 2007; Murray & Pizzorno, 2005). In fact, some of those foods and 
even dietary practices confer immediate therapeutic actions.  
In the last years, numerous changes have been observed in daily diets, in part due to the 
modern lifestyle and globalization (Goodman et al., 2011; Kaushik, Satya, Khandelwal, 
& Naik, 2010). Sensorial gratification is one of the most important points in food 
choices by individuals, but it does not mean that provides correct nourishment (Murray 
& Pizzorno, 2012). Increasing evidences have shown that diets rich in plant foods is 
protective towards a wide variety of health conditions; and in contrary, diets’ providing 
a low percentage of plant foods are considered a triggering factor to the development of 
human organisms disorders (Murray & Pizzorno, 2005, 2012). In fact, a substantial 
prevalence of chronic and degenerative disorders has been observed, which curiously 
becomes more frequent with the implementation of globalization and changes in dietary 
patterns. Metabolic (obesity, gout, diabetes), cardiovascular (high blood pressure, 
varicose veins, embolisms, strokes, arteriosclerosis, hearth dysfunctions), 
gastrointestinal (constipation, diverticulitis, bowel inflammatory syndromes, ulcers, 
haemorrhoids), and auto-immune disorders, and even cancer, are among the most 
frequent, with the highest rates of incapacity and dependence in worldwide population 
(Espín et al., 2007; Fernandez-Panchon et al., 2008; Murray & Pizzorno, 2012; Rubió et 
al., 2013). 
 
2.2. From nutritional attributes to effective biological functions 
Considering that enriched-diets in fruits and vegetables have been suggested to provide 
a dose-dependent protective effect against chronic disorders, numerous studies have 
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been carried out towards to support those evidences (Rubió et al., 2013). Among the 
numerous publications, researchers have highlighted that fruits and vegetables act as 
barrier against cancer, branding them as “chemopreventers”, due to the presence of 
bioactive “phytochemicals” (Murray & Pizzorno, 2012). These plant-derived molecules 
comprise pigments, such as chlorophyll, carotenes, flavonoids and other phenolic 
compounds; vitamins; dietary fibers, enzymes, minerals, among other minor 
constituents (Devasagayam et al., 2004; Grotewold, 2006; Murray & Pizzorno, 2005). 
In addition, they establish relations with other plant constituents including those through 
synergistic mechanisms (Ndhlala, Stafford, & Staden, 2013). This explains why in 
many cases whole matrices give a higher protection than isolated/single nutrients. 
Despite being vestigial components, phytochemicals play a crucial role in preventing 
and treating illnesses.  
Regarding phenolic compounds, increasing evidences prove their protective activity 
against a multitude of human conditions (Carocho & Ferreira, 2013; Grotewold, 2006; 
Mukherjee & Houghton, 2009). Mainly responsible for colour, smell and even 
protection of fruits and flowers, these phytochemicals possess really important bioactive 
attributes. Despite being each class of phenolic compounds mainly responsible for a 
specific bioactivity, they commonly evidence polyvalence reactions, being even able to 
strengthen the potential of other compounds, to block side effects of some constituents 
and also to acquire other biological properties (when combined in whole matrices) 
(Mukherjee & Houghton, 2009). Antioxidant activity is one of the most studied 
bioactive potential of phenolic compounds, in spite of the difficulty to quantify in an 
accurate mode, mainly through in vitro studies. Numerous variables act as conditioning 
factors; so, false-positive or negative results could be achieved. For example, phenolic 
matrices with pronounced in vitro antioxidant activity, could not have the same efficacy 
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when in vivo studies are carried out; but, the opposite effect can also occur (Halliwell, 
2012; Heim et al., 2002; Mukherjee & Houghton, 2009). This fact could be explained 
mainly due to two main reasons: firstly, in vitro studies do not consider whole human 
metabolism, biological barriers and the entire chemical reactions of the human 
organism; on the other hand, some compounds, ingested on their active form lack the 
bioactive potential after metabolism, while others acquire their bioactive form only after 
being metabolized (Espín et al., 2007; Heim et al., 2002; Holst & Williamson, 2008). In 
addition, it is also important to highlight that biochemical interactions (between 
phytochemicals and foods/drugs) could eliminate, reduce and even improve their 
bioactivity, making these compounds harmful or beneficial to the organisms 
(Fernandez-Panchon et al., 2008; Holst & Williamson, 2008).  
 
2.3. Benefits and constraints beyond human metabolism 
Human organisms need a correct metabolic function in order to ensure a good health 
and well-being. Through human metabolism, numerous harmful substances (commonly 
known as free radicals) are produced and, therefore, effective endogenous detoxifying 
and neutralizing processes need to function properly in order to prevent damages 
(Devasagayam et al., 2004; Valko et al., 2007). Superoxide dismutase (SOD), catalase 
(CAT) and glutathione peroxidase (GSH-Px) are the three most important enzymes 
(considered primary enzymes) involved in the direct elimination of reactive oxygen 
species- ROS (hydroxyl radical, superoxide radical, hydrogen peroxide, peroxyl radical, 
hydroperoxide, singlet oxygen), through metabolism of those toxic oxidative 
intermediates (Devasagayam et al., 2004; Singh et al., 2004; Valko et al., 2007). On the 
other hand, the secondary enzymes glutathione reductase (GR), glucose-6-phosphate 
dehydrogenase (G-6-PDH), and glutathione-S-transferase (GST) are involved in the 
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detoxification of ROS by decreasing peroxide levels or maintaining a correct supply of 
metabolic intermediates (such as glutathione and NADPH), crucial for an optimum 
functioning of the primary antioxidant enzymes (Singh et al., 2004). Notwithstanding, 
endogenous metabolism is also a source of harmful substances; stress, underlying 
diseases/disorders, ingested chemicals and drugs, pesticides and other food 
contaminants are able to attack organisms. In addition, pollution, modern lifestyle, 
radiations, inadequate behaviours, dependencies, among other factors comprise 
important aggressors, which also improve free radicals production (Devasagayam et al., 
2004; Singh et al., 2004; Valko et al., 2007).  
One of the most important and basic functions of cells is to maintain homeostasis; 
however, by itself, the proper human metabolism is a triggering factor to cellular 
unbalance and, consequently, dysfunction. Furthermore, in face of a poor nutritional 
status and weak ingestion of antioxidant phytochemicals, associated with a continuous 
exposure to toxic substances (mainly by oral or dermal routes and inhalation), a higher 
risk to develop disease/dysfunction will be doubtless installed (Valko et al., 2007). In 
addition, and considering the modern lifestyle, the human endogenous detoxifying and 
antioxidant processes of the organisms are not able to neutralize the free radicals 
produced daily. Still more, endogenous antioxidants require an appropriate supplying of 
micronutrients and other functional biomolecules, which act mainly as cofactors, in 
order to ensure an optimal functioning (Fardet, Rock, & Rémésy, 2008; Singh et al., 
2004).  
In this sense, it is of the utmost importance to provide enriched-food sources of 
antioxidants. As referred above, phenolic matrices comprise an extremely rich source of 
phytochemicals, which present a multitude of health benefits, including their ability to 
act as free radicals scavengers. Currently, several controversies still exist and no definite 
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consensus has been established on the antioxidant potential of natural matrices (Carocho 
& Ferreira, 2013). It is obvious that not all the studied variables can be controlled; itself, 
this is a sufficient fact, which leads to different conclusions. On the other hand, when in 
vivo studies are carried out, additional confusing factors are present which cannot be 
fully controlled. For example, the interference of some foods and even nutrients on the 
bioavailability and bioactivity of phenolic matrices is doubtless established, with milk 
being one of the most studied. Several reports have evidenced that milk interferes with 
the antioxidant potential of enriched-phenolic matrices, including blueberries (Serafini 
et al., 2009), tea (Langley-Evans, 2000a; Lorenz et al., 2007) and chocolate (Serafini et 
al., 2003). However, other authors have also reported contradictory results for the same 
phenolic matrices (Hof, Kivits, Weststrate, & Tijburg, 1998; Hollman, Hof, Tijburg, & 
Katan, 2001; Leenen, Roodenburg, Tijburg, & Wiseman, 2000). Thus, as in vivo studies 
are poorly developed, those contradictions remain unclear. 
 
3. In vitro vs. in vivo studies: challenges and current perspectives 
Medicinal plants have deserved an increasing interest in the last years. In fact, they 
possess a multitude of health benefits, widely known since pre-historic era. 
Notwithstanding, due to the absence of scientific validation, they were poorly 
recommended and even used by worldwide population; but, currently, significant 
changes have been achieved (Halberstein, 2005). Among the bioactive properties, the 
antioxidant potential has been one of the most studied, for numerous plant species, 
different plant parts, extraction procedures and evaluation assays. But even other 
bioactive properties have been increasingly studied (Dai & Mumper, 2010; Rubió et al., 
2013). Obviously studying the in vitro properties of natural matrices should be the first 
objective to carry out; but, numerous studies in which promising antioxidant effects 
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were achieved, lack of in vivo validation (Fernandez-Panchon et al., 2008; Rubió et al., 
2013). For example, by comparing the number of publications, from 2000 up to 2014, a 
pronounced increase on the magnitude of studies in which the in vitro and in vivo 
antioxidant potential of phenolic matrices have been observed. However, still remains 
existing a significant gap related with the in vivo validation of the antioxidant potential 
of phenolic extracts. Further, numerous studies report effective in vitro antioxidant 
potential of natural matrices, in an exponential manner; but in vivo studies are still 
scarce. Another interesting fact is that, contrarily to in vitro studies, the in vivo 
experiments do not follow the previously mentioned exponential growth. Normally, in 
vivo studies are developed by using several animal models; however, to the majority of 
the tested phenolic matrices, in which significant free radicals scavenging activity was 
observed, no in vivo studies were carried out to confirm this potential. The study of new 
phenolic matrices is undoubtedly important, but to deepen its potential, namely through 
chemical characterization of the bioactive constituents, followed by testing the in vivo 
potential and related mechanisms of action, if applicable, carrying out clinical trials, is 
of the utmost importance. It is important to highlight that in vitro methods possess 
numerous constraints, and for that reason, a significant variation is observed when 
different methods are used to evaluate the same biochemical parameter. In addition, it is 
very important not forget that the whole human metabolism gives a significant 
contribution to the antioxidant potential. Through the entire human metabolism 
numerous compounds are converted on their active forms, while others are inactivated 
or even linked to several biomolecules that can change the original effect. None of those 
aspects could be achieved by using in vitro studies, and apart from that, false-negative 
and false-positive results could be achieved. Therefore, in vivo studies should be carried 
out to confirm the in vitro results. 
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Besides phenolic matrices, the in vitro and also in vivo antioxidant potential of 
individual phenolic compounds, derived from natural matrices, has been also carried 
out. By observing the number of publications, from 2000 up to 2014, in which the in 
vitro and in vivo antioxidant potential of phenolic compounds was accessed, similarly to 
phenolic extracts, in vitro studies have increased exponentially, while in vivo 
experiments remain poorly investigated. Furthermore, despite the evaluation of specific 
compounds, not least important is to evaluate synergisms, antagonisms, polyvalence 
reactions and even lack of biological effect in mixtures of those compounds. Individual 
phenolic constituents exist in different proportions in whole natural matrices; so, the 
final observed potential is not always the sum of each one of the individual phenolic 
compounds present.  
Currently, numerous phytochemical formulations are available, not only including plant 
crude extracts but also isolated phenolic compounds, mixtures of them or even with 
other biological constituents (vitamins, minerals, trace elements, among others). In this 
sense, apart from the elucidation of the effects of isolated and even mixtures of phenolic 
compounds derived from natural matrices, through in vitro studies, the development of 
in vivo experiments is of the major importance. Clinical trials should be also carried out, 
as well as the validation of numerous phytochemical formulations used for antioxidant 
purposes. 
 
4. In vivo antioxidant activity of phenolic extracts/compounds 
4.1. Plant phenolic extracts with in vivo antioxidant activity 
Animal models comprise the main focus of the studies towards evaluating in vivo 
antioxidant activity of phenolic matrices (Table 1). Rats (Wistar and albino Wistar, 
Sprague Dawley and Wistar-Hannover), followed by mice (Swiss, Kunming and CF1) 
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and Swiss albino inbred mouse, are the most frequently used laboratory animals. Those 
animals are submitted to a broad spectrum of stress-inducing agents, such as ethanol, D-
galactose, iron, alloxan, streptozotocin (STZ), carbon tetrachloride (CCl4), 
bromobenzene, radiation, noise exposure, methylmercuric chloride (MeHgCl), tert-butyl 
hydroperoxide (t-BOOH) and hydrogen peroxide (H202).  
Acetone, chloroform, ethanol, ethyl acetate, methanol, water, ethanol:water, 
acetone:water:HCl, petroleum ether, and methanol:1N HCl were used as solvents to 
obtain the different phenolic extracts tested. Plant species belonging to Leguminoseae 
and Rhamnaceae, followed by Fabaceae, Poaceae, Rubiaceae, Nymphaeaceae, Rosaceae 
and Moringaceae have been mostly studied as sources of phenolic extracts. However, 
Anacardiaceae, Annoneaeceae, Apiaceae, Asteraceae, Cannabaceae, Chenopodiaceae, 
Ericaceae, Lamiaceae, Liliaceae, Moraceae, Myrtaceae, Passifloraceae, Pinaceae, 
Schisandraceae, Solanaceae, Symplococaceae, Umbeliferae, Verbenaceae and Vitaceae 
have also been used.  
The evaluation of the in vivo antioxidant potential is mainly assessed by the effects on 
different biochemical parameters directly involved in the maintenance of a 
balanced/correct antioxidant status, such as: malondialdehyde (MDA), CAT, SOD, 
glutathione (GSH), GSH-Px, GST, GR, xanthine oxidase (XOD), peroxidase (Px), 
alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate 
dehydrogenase (LDH), alkaline phosphatase (ALP), c-Glutamyl transpeptidase (c-GT), 
ferric reducing antioxidant power (FRAP), 2,2′-azobis(2-amidino-propane) 
dihydrochloride (APPH)-hemolysis, protein carbonylation (PC), diene conjugates, 
collagen glycation, total antioxidant capacity (TAOC), monoamine oxidase (MAO), 
oxidative hemolysis, oxygen radical absorbance capacity (ORAC), gamma glutamyl 
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transferase (GGT), glutamate oxaloacetate transaminases (GOT), glutamate pyruvate 
transaminases (GPT) and 2,2-azino-bis(3-ethyl-benzothiazoline-6-sulphonate (ABTS). 
Table 2 shows the in vivo antioxidant potential of phenolic extracts, evaluated through 
clinical trials, using healthy human volunteers or groups of individuals in special 
physiological conditions, namely basketball players during training (Chang et al., 2007), 
postmenopausal women (Lorenz et al., 2007) and human pre-diabetic Mauritians 
(Somanah, Bourdon, Rondeau, Bahorun, & Aruoma, 2014). Among of the studied plant 
families only five of them were also previously studied in animal models: Asteraceae, 
Ericaceae, Myrtaceae, Rosaceae and Vitaceae, but not the same extract types.  
Lactuca sativa L. and Helichrysum plicatum ssp. plicatum capitulums were the studied 
Asteraceae plant extracts tested in human volunteers and Wistar-albino rats, 
respectively. Among to the Ericaceae family, Vaccinium angustifolium Ait. and 
Vaccinium corymbosum L. were studied in healthy human volunteers, while Vaccinium 
ashei (Mau and Centurion varieties) was tested in Sprague Dawley rats. In the 
Myrtaceae family, Ugni molinae Turcz. and Myrciaria dubia McVaugh were studied in 
human healthy volunteers and STZ-induced diabetic Wistar rats, respectively. In 
relation to Rosaceae family, while Fragaria ananassa Duch was tested in human 
healthy volunteers, Cydonia oblonga Mill. cv. Smyrna, Malus domestica Borkh. cv. 
Fugi and Pseudocydonia sinenses Schneid. var. Toukarin were evaluated in healthy 
Wistar rats. Lastly, among the Vitaceae family, Vitis vinifera L. extract was tested in 
human healthy volunteers, and different V. vinifera varieties were also studied in 
healthy Swiss mice. Other plant families tested in human volunteers include Caricaceae, 
Convolvulaceae, Malvaceae and Theaceae. Total radical trapping parameter (TRAP), 
FRAP, total antioxidant status (TAS), ORAC, luminal-enhanced chemiluminescence 
measurement (LCL), PC, GSH, MDA, 8-hydroxy-2-deoxyguanosine (8-OHdG), 4-
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hydroxynonenal (4-HNE), trolox equivalent antioxidant capacity-cupric ion reducing 
antioxidant capacity (TEAC-CUPRAC), endothelial function, lipid hydroperoxides and 
inhibition of hemolysis were the most commonly methods to evaluate human 
biochemical parameters (as shown in the Table 2).  
As previously mentioned, for the majority of the plant extracts tested in animal models, 
in which pronounced antioxidant properties were observed, no clinical trials involving 
human volunteers were carried out. Nevertheless, it is important to highlight that the 
achievement of a significant antioxidant potential in animal models (rats, mice, mouse, 
etc.) does not mean that the same potential will be found in human individuals. It is 
important to clearly understand the real effects of plant phenolic extracts, their bioactive 
individual compounds and mechanisms of action, and even to establish prophylactic and 
therapeutic doses, not only in animal models but also in human individuals.  
 
4.2. Phenolic compounds with in vivo antioxidant activity 
Table 3 shows the in vivo antioxidant potential of individual phenolic compounds, by 
using animal models. Anthocyanins, followed by hydroxybenzoic and hydroxycinnamic 
acids comprise the most studied phenolic classes. Flavones, flavonols, coumestans, 
diferuloylmethanes and simple phenols, were also studied. Similarly to the phenolic 
extracts, rats (Wistar, Sprague-Dawley, Rowett Hooded Lister strain) and mice (ICR, 
Kunming) are the most commonly used animal models, followed by Hartley albino 
guinea-pigs and the marine fish Dicentrarchus labrax. The measured biochemical 
parameters include MDA, CAT, SOD, GSH, GSH-Px, Px, ALT, AST, AAPH, TAOC, 
ORAC, 4-HNE, heme oxygenase-1 (HO-1), lipid hydroperoxides, 8-OHdG, learning 
and memory abilities, auditory brain response, immunohistochemical and western blot 
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analysis (Nrf2, NQO1 and HO-1), as well as the recovery levels of ferulic (FA) and p-
coumaric (PCA) acids, and related metabolites.  
Since 2010, a significant improvement of the in vitro studies was observed, in which the 
antioxidant potential of phenolic compounds has been studied; however, a small portion 
evaluated its in vivo potential. The most tested phenolic compounds are purchased from 
commercial sources, while those isolated from natural matrices are considerably scarce. 
Leaves of Apium graveolens L. var. dulce (apiin), corn bran (FA and PCA), Alpinia 
oxyphylla Miq. (protocatechuic acid), Abies koreana E.H. Wilson (cyanidin 3-
glucoside, delphinidin 3-glucoside, malvidin 3-glucoside, peonidin 3-glucoside and 
petunidin 3-glucoside) and Ipomoea batatas (L.) Lam. (anthocyanin) seems to be the 
main phenolic matrices from which phenolic compounds were isolated, towards the 
evaluation of in vivo antioxidant effects. It is a fact that numerous phenolic compounds 
are common in several plant species, but the existence of tenuous differences on their 
relative abundance is, normally, predictor of the bioactive potential (Avello et al., 2013; 
Naghdi Badi, Yazdani, Ali, & Nazari, 2004; Parker, Wang, Pazmiño, & Engeseth, 2007; 
Wojdylo, Oszmianski, & Czemerys, 2007).  
Numerous and significant advances have been reported, highlighting the antioxidant 
potential of individual phenolic compounds. Among them, apigenin, quercetin, 
kaempferol, myricetin, luteolin, isorhamnetin, neochlorogenic, caffeic, ferulic and p-
coumaric acids, and their derivatives are the most reported (Heim et al., 2002; 
Sulaiman, Sajak, Ooi, & Seow, 2011; Wojdylo et al., 2007). So, and despite the 
evidences of promising antioxidant potential, mainly through in vitro experiments, it is 
urgent to validate the in vivo activity of these and other phenolic constituents of plant 
species. In addition, apart from the effect of slight differences on the phenolic 
composition, geographical and environmental variations, harvesting time, storage and 
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even extraction procedures are also able to produce considerable variations in phenolic 
plant contents, and consequently on their total antioxidant potential. Several studies 
have also reported that different culture conditions are able to produce significant 
changes on the phenolic composition of the same plant (Avello et al., 2013; Farhat, 
Landoulsi, Chaouch-Hamada, Sotomayor, & Jordán, 2013; Sulaiman et al., 2011).  
By analysing Figure 1 reporting studies in which phenolic compounds were evaluated 
for in vivo antioxidant potential in human volunteers, other significant constraints could 
be observed. Firstly, from the in vivo experiments in animal models, only three of the 
studied phenolic compounds were further studied in human volunteers: gallic acid, 
ferulic acid and rutin. The relative antioxidant efficiency (RAE) of those compounds 
varied between 17.2 and 27.0%, while for the others, RAE was lower than that. Only 
ellagic acid (RAE=109.9%), caffeic acid (RAE=40.2%), epigallocatechin gallate 
(RAE=43.1%), eriodictyol (RAE=40.8%), taxifolin (30.7%), apigenin (RAE=35.3%), 
kaempferol (RAE=58.8%), quercetin (RAE=59.1%), sesamin (RAE=109.9%) and 
sesaminol (RAE=56.4%) evidenced a higher potential. However, as previously 
mentioned, it is important to highlight that those compounds are widely recognized for 
their antioxidant properties, being even used as food preservatives. Additionally, some 
researchers also use them as positive controls, in order to assess the bioactive properties 
of other compounds/substances. Interestingly, Wang and Goodman (1999) only used 
commercial compounds on their experiment, remaining unclear the real antioxidant 
effect of these phenolic compounds, isolated from natural sources, as well as their 
bioavailability and bio-efficacy. In fact, several reports have shown that the recovery of 
phenolic compounds in plasma, urine and faeces, after ingestion of enriched-natural 
matrices in phenolic compounds, is poor (Serafini et al., 2002; Z. Zhao et al., 2009; Z. 
Zhao, Egashira, & Sanada, 2005).  
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In relation to the in vivo antioxidant potential of anthocyanins from Vaccinium 
angustifolium Ait., tested in human volunteers (Figure 2), only four of them were 
previously studied in animal models, but isolated from a different natural source (Abies 
koreana E.H. Wilson). Cyanidin 3-O-glucoside, delphinidin 3-O-glucoside, malvidin 3-
O-glucoside and petunidin 3-O-glucoside were the isolated anthocyanins from natural 
sources in which in vivo experiments, both using animal models and human healthy 
volunteers, were carried out. Curiously, Abies koreana E.H. Wilson presented a higher 
relative abundance of anthocyanins than Vaccinium angustifolium Ait.: 1.3625 g total 
antocyanins/100 g (Ramirez-Tortosa et al., 2001) and 1.20 g total anthocyanins/100 g 
(Mazza, Kay, Cottrell, & Holub, 2002), respectively. Considering these results, it is 
important to highlight that numerous matrices with in vitro and in vivo significant 
antioxidant potential, could be highly effective and bioavailable, in human individuals. 
But, as no clinical trials are available for the majority of them, their effect remains 
questionable.  
 
4. Bioavailability and bio-efficacy: conditioning factors 
Plant phytochemicals possess numerous health benefits, and despite the chemical 
composition of each species determines/predicts the final bioactive potential, 
geographical, environmental and culture conditions, harvesting time, storage, extraction 
procedures, type of solvents and plant parts used, also have a pronounced impact 
(Naghdi Badi et al., 2004; Taârit et al., 2012). In fact, several studies have described the 
effect of each one of the previously described triggering factors, being in vitro studies 
the most frequently used for this purpose. Besides, it has also been described that 
several phenolic matrices with in vitro bioactive potential, particularly anti-oxidative 
effects, do not present the same potential throughout in vivo studies, and vice-versa. 
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Furthermore, the presence of these phenolic compounds in free or bound forms directly 
influences their potential. For example, Germano et al. (2006) evaluated the in vivo 
antioxidant potential of phenolic acids, isolated from Trichilia emetica Vahl., in male 
Wistar rats, and observed significant differences on the phenolic contents, directly 
dependent from the type of applied treatment (alkaline hydrolysis vs. no treatment). 
Then, using the free and bound phenolic extract forms, pronounced variations on their 
ability to inhibit methyl linoleate (MeLo) autoxidation were observed: phenolic extracts 
submitted to alkaline hydrolysis presented a higher antioxidant potential. Similar results 
were achieved in the ascorbate/Fe2+ - induced lipid peroxidation assay. Afterwards, the 
phenolic acids content was measured in plasma, before and after β-glucoronidase 
treatment; the authors observed that the most abundant phenolic acids (caffeic, p-
coumaric, protocathecuic, vanillic and galic acids), appeared in higher concentration in 
plasma in comparison with hydrolyzed phenolic extracts (Germanò et al., 2006). Taking 
into account the obtained results, it is evident that some phenolic extracts and, therefore, 
phenolic compounds, need to be metabolized to be biologically active. Currently, there 
are no doubts about the importance of the assessment of the in vivo biological potential 
in phenolic matrices with significant in vitro potential. Fardet et al. (2008), reported 
similar results, namely the effects of metabolism on the bioavailability of whole-grain 
cereals and cereal products. In contrast, other authors have reported that some phenolic 
extracts and even phenolic compounds display a lower bioavailability after ingestion (Z. 
Zhao et al., 2005). 
There are increasing evidences that important food-phenolic compounds interactions 
affect their bioavailability, and consequently biological potential. One of the most 
studied are milk-phenolic interactions (Fernandez-Panchon et al., 2008). For example, 
Serafini et al. (2009) observed that the ingestion of Vaccinium corymbosum L. 
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(blueberries) fruit results in a significant increase of the endogenous plasma antioxidant 
defences, and also caffeic and ferulic acids level. In addition, they observed that, post-
ingestion, caffeic acid was found in plasma, but not in the food matrix. It means that 
metabolism favours its absorption and appearance in the circulatory system. Otherwise, 
the ingestion of blueberries in association with milk impaired the in vivo antioxidant 
properties of blueberries, and reduced the absorption of caffeic acid (Serafini et al., 
2009). But, numerous controversies still remain unclear; while some authors described 
that milk impairs the bioavailability of phenolic extracts/compounds (Langley-Evans, 
2000b; Serafini et al., 2003, 2009), other concluded that no significant interactions were 
observed (Hof et al., 1998; Hollman et al., 2001; Leenen et al., 2000).  
Bioavailability is commonly defined as the amount of a food constituent that is present 
in the gut, as a consequence of the release of this constituent from the solid food matrix, 
and may be able to pass through the intestinal barrier (Saura-Calixto, Serrano, & Goñi, 
2007). Different steps directly contribute to this process, namely liberation, absorption, 
distribution, metabolism and elimination. As previously cited, and despite several 
variables each one determining the previous steps, inter-individual variations possess a 
large influence on these processes (M. J. Rein et al., 2013). One of the first and most 
important factors in the bioavailability is the bioaccessibility: fraction of a compound, 
which is released from the food matrix in the gastrointestinal lumen and that becomes 
available for intestinal absorption (M. J. Rein et al., 2013), or the amount of compound 
reaching the enterocyte in a form suitable for absorption (Scholz & Williamson, 2007). 
From a nutritional perspective, the composition of the digested food matrix, the 
existence of synergic and antagonistic reactions between the different components, and 
also physicochemical properties (pH, temperature, texture, etc.) influence this process, 
apart from the mastication (M. J. Rein et al., 2013). Particularly to the plant foods, 
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another special consideration needs to be highlighted. The composition of plant cell 
wall is markedly resistant to degradation in the upper gut that, therefore, makes difficult 
the liberation of the active constituents, such as phenolic compounds. Those facts were 
previously discussed and widely confirmed by some authors. In fact, different reports 
have stated the benefits of hydrolysis, fermentation, dissolution and even mixture of 
different phenolic matrices in the improvement of polyphenols bioavailability and its 
biological potential (Dey & Kuhad, 2014; Fardet et al., 2008; Kountouri, Mylona, 
Kaliora, & Andrikopoulos, 2007; Pinelo, Landbo, Vikbjerg, & Meyer, 2006; Scalbert et 
al., 2000). But, extensive studies, which aim to understand the real interference of those 
methodologies on the improvement of phenolic matrices bioavailability, are 
significantly scarce. However, it is important to refer that this is a key step to ensure the 
bio-efficacy of plant bioactive compounds (M. J. Rein et al., 2013). So, it is crucial to 
enhance the knowledge in this area.  
Until now, apart from the bioacessibility, the absorption of these compounds can be also 
influenced by solubility, interaction with some dietary constituents, molecular changes, 
protein transporters, human organisms metabolism and, lastly, effects of gut microbiota 
(M. J. Rein et al., 2013). Those factors, considered the most important determinants to 
the bioavailability, and then bio-efficacy of bioactive compounds, are schematically 
described in Figure 3. Plant bioactive compounds need to be bioavailable to exert 
beneficial effects in order to provide a significant improvement of health and well-being 
of the worldwide population, mainly by reducing the frequency of oxidative-stress 
related diseases/disorders.  
 
5. Aging-related diseases: evidences of the in vivo role of phenolic antioxidants 
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The improvement of the life expectancy and longevity comprises one of the most 
important purposes of human individuals. Over decades, aging was considered a natural 
process, i.e. a normal phase, in which a progressive decrease in function, degeneration 
and malfunction of cells is observed; therefore, cells start to die at a faster rate than new 
ones are generated. In fact, birth, growth and death markedly represent the three most 
significant phases of the organisms’ life cycle (Murray & Pizzorno, 2012). However, 
with the advances of science and technology, new achievements have been stated.  
The modern definition of aging comprises a progressive post-maturation decline in 
physiological capacity, accompanied by an increased susceptibility to disease and 
mortality risk (Ergin, Hariry, & Karasu, 2013). In fact, the common aging process is 
associated with a progressive cell failure and, consequently, improves the probability of 
occurrence of dysfunction/disease/disorders. Notwithstanding, numerous causes of 
premature aging and cell death have been pointed out during the past decades. It is 
convenient to highlight that formerly the poor health and hygiene conditions, and 
medical assistance impaired significantly the life expectancy and increased infant 
mortality. Currently, in parallel with the improvement of life expectancy, increasing 
rates of premature aging and death have also been observed (Chaturvedi & Beal, 2013; 
Murray & Pizzorno, 2012). However, cardiovascular, neurodegenerative, 
gastrointestinal and metabolic diseases, and even cancer comprise the main causes of 
morbidity and mortality (Valko et al., 2007). More recently, auto-immune, respiratory 
and osteoarticular disorders have increased their frequency (Musumeci, Szychlinska, & 
Mobasheri, 2015; Rubió et al., 2013; Valko et al., 2007).  
Pollution, smoking, obesity, sedentary lifestyle, poor nutrition and nutritional 
deficiencies are pointed as the main contributor factors. It appears a paradox, because in 
association with greater dietary availabilities and food choices, higher rates of 
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nutritional deficiencies and human disorders/diseases are observed (Murray & Pizzorno, 
2012). Per se, the physical exercise is a triggering factor that accelerates the aging 
process, while rich source of free radicals; but physical inactivity too, besides to be 
more dangerous. Apart from the importance of stress management, physical activity, 
health-promoting lifestyle, and dietary choices are of utmost importance. 
All of the most important causes of death are directly related with dietary practices. 
Dairy products, meat and cereals comprise the base of nutrition to the majority of 
individuals, while fruits and vegetables/plant products are consumed in a lower 
frequency than expected. Extremely rich in vitamins, minerals, trace elements, fibers, 
and also numerous phytochemicals, among them phenolic compounds, those natural 
matrices have proved to be promising prophylactic and therapeutic agents, widely 
known in traditional medicine since ancient times (Vanaclocha & Cañigueral, 2003). 
Particularly in relation to their antioxidant activity, those plant phytochemicals act not 
only as free radical scavengers, metal chelators, hydrogen donators and oxygen 
quenchers, but also they recycle other antioxidant compounds, promote an adequate 
homeostasis and proper enzymatic function, among other benefits (some of them are not 
yet discovered) (Carocho & Ferreira, 2013; Dai & Mumper, 2010; A. Li et al., 2014).  
Apart from the extensive knowledge about the antioxidant activity of natural matrices, 
mainly obtained from in vitro studies, recently, new advances regarding in vivo studies 
have been shared. A significant part of them, have focused on the study of phenolic 
matrices and not so much on isolated/individual compounds. From the in vivo studies, a 
great part of phenolic matrices exerts its effects by inhibition of the ROS formation and 
reduction of oxidative stress, as also by preventing tissue damages (mainly when 
oxidative stress-inducers are administered) (Shi, An, Jiang, Guan, & Bao, 2006; Silva et 
al., 2013; Su, Wang, & Liu, 2009). The effects on gut microbiota are also being 
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increasingly studied; in fact, not only several phenolic matrices are converted on their 
active forms but also they exert directional modulatory activities on the gut microbiota, 
by inhibition of opportunistic flora without interfering with the beneficial bacteria. 
However, the mechanisms of action are not completely understood (Cueva et al., 2010; 
Silva et al., 2013; Velderrain-Rodríguez et al., 2014). On the other hand, several 
isolated phytochemicals, for example, curcumin, exert their effects by causing arsenic 
methylation and improvement of urinary elimination, apart from the Nrf2 nuclear 
translocation, activation of Nrf2 regulation proteins, and promote detoxification of 
antioxidant enzymes (Gao et al., 2013). 
 
6. Concluding remarks and future perspectives 
The study of biological effects of natural matrices, including the discovering of their 
active constituents, is a hot topic that focuses the attention of numerous scientists. In 
fact, the use of botanical preparations dates since pre-historic era, but due to the lack of 
scientific evidences, including modes of action, no solid recognition or assertion was 
achieved. Prior to the use of synthetic drugs, botanical preparations were used for a 
multitude of health conditions, as also for averting the aging process. Then, with the 
increasing use of synthetic molecules, natural therapies passed to a second stage. But, 
currently, the focus on natural matrices (namely, rich in phenolic compounds) properties 
has gained attention. In vitro studies increased in an exponential manner, and numerous 
bioactive properties were confirmed; then, in vivo studies mainly in animal models have 
also increased, but in smaller proportions.  
Despite those advances, to the majority of plant species no extensive knowledge is 
available, namely the responsible phytochemicals for the observed bioactivity, their 
mechanisms of action, therapeutic and prophylactic doses, synergism, antagonisms and 
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other inter-relations between them. Clinical trials are very important, in order to develop 
future and effective alternatives to improve the health and well-being of individuals. In 
addition, it is of the major importance to prove the effective therapeutic potential of 
phytochemical preparations, together with the increasing number of publications related 
with the discovery of plant species with bioactive potential, as well as to evaluate other 
variables, such as bioavailability and bio-efficacy, nutrient-phytochemicals and drug-
phytochemicals interactions. 
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Table 1. Plant species used to obtain phenolic extracts with in vivo antioxidant activity evaluated in animal models. 
Plant  References  Plant  References 
Afzelia africana SM (Atawodi, Iliemene, & 
Onyike, 2014) 
 Ocimum sanctum L. (Samson, Sheeladevi, 
& Ravindran, 2007) 
Astragalus sinicus L. (Lim et al., 2011)  Parkia biglobosa (Ademiluyi & Oboh, 
2012) 
Beta vulgaris L. (Vulić et al., 2014)  Paspalum scrobiculatum L. (Hegde, Rajasekaran, 
& Chandra, 2005) 
Capsicum baccatum L. var. pendulum (Kappel et al., 2008) 
 
Passiflora edulis Sims (Silva et al., 2013) 
Cassia fistula Linn. 
(Maheep, Sunil, Yogesh, 
Durgesh, & Kanika, 
2010) 
Pinus koraiensis L. (Su et al., 2009) 
Ceratonia siliqua (Hsouna et al., 2011)  Piper guineense Schumach. et Thonn (Adefegha & Oboh, 
2012) 
Choerospondias axillaris (Roxb.) B.L. 
Burtt and A.W. Hill 
(H. Wang, Gao, Zhou, 
Cai, & Yao, 2008) 
 Prosopis juliflora (Almaraz-Abarca et 
al., 2007) 
Clerodendrum infortunatum L. 
(Gouthamchandra, 
Mahmood, & 
Manjunatha, 2010) 
 
Pseudocydonia sinensis Schneid. var. 
Toukarin 
(Hamauzu, Inno, 
Kume, Irie, & 
Hiramatsu, 2006) 
Coffea arabica (60%) and Coffea 
canefora var. robusta (40%) mixture 
(Contini, Baccelloni, 
Frangipane, Merendino, 
& Massantini, 2012) 
 Pueraria lobata (Willd.) Ohwi (Bebrevska et al., 
2010) 
Cydonia oblonga Mill. cv. Smyrna (Hamauzu et al., 2006)  Saccharum officinarum L. 
(Duarte-Almeida, 
Novoa, Linares, 
Lajolo, & Genovese, 
2006) 
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Dipteryx alata Vog. (Siqueira et al., 2012)  Saraca indica L. (Sen et al., 2014) 
Eleusine coracana (L.) Gaertn. (Hegde et al., 2005)  Schisandra chinensis (Cheng et al., 2013) 
Euryale ferox Salisb. (Wu et al., 2013)  Symplocos cochinchnensis var. laurina 
(Sunil & Ignacimuthu, 
2011) 
Ferula szovitsiana DC 
(Dehghan, Shafiee, 
Ghahremani, Ardestani, 
& Abdollahi, 2007) 
 Torilis leptophylla L. (Saeed, Khan, & 
Shabbir, 2012) 
Ficus glomerata Roxb. (Verma, Vijayakumar, 
Rao, & Mathela, 2010) 
 
Vaccinium ashei Reade (Maru and 
Centurion varieties) 
(Molan, Lila, & 
Mawson, 2008) 
Glycine max L. Merrill 
(Ademiluyi & Oboh, 
2012) 
 Vigna subterranea L. Verdc 
(Ademiluyi & Oboh, 
2012) 
Helichrysum plicatum ssp. plicatum  (Aslan, Orhan, Orhan, 
Sezik, & Yesilada, 2007) 
 Vigna unguiculata (Kapravelou et al., 
2015) 
Hemerocallis fulva Linn. (Que, Mao, & Zheng, 
2007) 
 Vitis vinifera varieties (Gris et al., 2013) 
Hordeum vulgare L. (Qingming et al., 2010)  Xylopia aethiopica (Dun.) A. Rich (Adefegha & Oboh, 
2012) 
Humulus lupulus L. (X. Wang, Yang, Yang, & 
Tian, 2014) 
 Zizyphus jujuba cv. Banzao 
(H. Zhao, Zhang, & 
Yang, 2014) 
Malus domestica Borkh. cv. Fuji (Hamauzu et al., 2006)  Zizyphus jujuba cv. Goutouzao 
Meyna spinosa Roxb. (Sen, De, Devanna, & 
Chakraborty, 2013) 
 Zizyphus jujuba cv. Jinsizao 
Moringa oleifera Lam. 
(Jaiswal et al., 2013; 
Verma, Vijayakumar, 
Mathela, & Rao, 2009) 
 Zizyphus jujuba cv. Junzao 
Myrciaria dubia McVaugh (Gonçalves, Lellis-Santos,  Zizyphus jujuba cv. Pozao 
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Curi, Lajolo, & 
Genovese, 2014) 
Nelumbo nucifera Gaertn. 
(Huang et al., 2010; Rai, 
Wahile, Mukherjee, Saha, 
& Mukherjee, 2006) 
 Zizyphus jujuba cv. Yuzao 
 Zizyphus jujuba cv. Xiaozao 
	 40 
Table 2. Plant phenolic extracts with in vivo antioxidant activity evaluated in clinical trials with human healthy volunteers. 
Family Plant  Preparation Concentration Dosage  Period Assays References 
Asteraceae 
Lactuca sativa 
L. 
Fresh lettuce 
250 g/day Single dose 1 day TRAP 
(Serafini et 
al., 2002) Stored lettuce 
Caricaceae 
Carica papaya 
L. 
Fermented ripe 
pulp 
30 mg/mL 1 dose (200 mL)/day  14 weeks a) 
TAS, inhibition of 
hemolysis and level 
of PC 
(Somanah 
et al., 
2014) 
Convolvulaceae 
Ipomoea 
batatas (L.) 
Lam. 
Cooked leaves 200 g/day 
2 doses (each 100 g) 7 weeks 
TAS, GSH, 8-
OHdG, MDA, 4-
HNE 
(Chen et 
al., 2008) 
Single dose 
2 periods 
(each lasting 
2 weeks) b) 
TAS, lipid 
hydroperoxides, 8-
OHdG, MDA  
(Chang et 
al., 2007) 
Ericaceae 
Vaccinium 
angustifolium 
Ait. 
Freeze-dried 
wild strawberry 
dispersed in 
water 
200 mg/mL 1 dose/day 7 days ORAC and TAS 
(Kay & 
Holub, 
2002) 
Vaccinium 
corymbosum L. Fresh fruits 200 g/day 1 dose/week 2 weeks 
TAS, FRAP and 
TRAP 
(Serafini et 
al., 2009) 
Malvaceae 
Theobroma 
cacao L. 
M&M’s Semi- 
Sweet 
Chocolate Mini 
Baking Bits 
105 g (80 g of 
procyanidin-
rich chocolate) 
Single dose 1 day 
TBARS, TRAP and 
LCL 
(D. Rein et 
al., 2000) 
Commercial 
product 
100 g Single dose 1 day FRAP 
(Serafini et 
al., 2003) 
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Myrtaceae 
Ugni molinae 
Turcz. 
Infusion of 
leaves 
10 mg/mL 
2 doses (100 
mL)/day 
3 days 
TBARS, and 
TEAC-CUPRAC 
(Avello et 
al., 2013) 
Oleaceae Olea europaea  Fresh fruits 100 g/day Single dose 24 h TAS, plasma total 
polyphenol assay 
(Kountouri 
et al., 
2007) 
Rosaceae 
Fragaria x 
ananassa, 
Duch. 
Fresh fruit 500 g 2 doses (250 g)/day 16 days 
FRAP and TEAC, 
erythrocytes 
hemolysis 
(Tulipani 
et al., 
2011) 
Theaceae 
Camelia 
sinensis (L.) 
Kuntze 
Black tea 
16.25 mg/mL Six doses (200 mL) 1 day FRAP 
(Langley-
Evans, 
2000b) 
6.67 mg/mL 
Single dose (300 
mL) 
1 day FRAP 
(Leenen et 
al., 2000) 
20 mg/mL 
Single dose (300 
mL) 
1 day TRAP 
(Serafini, 
Laranjinha, 
Almeida, 
& Maiani, 
2000) 
3.33 mg/mL 
Eight doses (150 
mL)/ day, every 2h 
3 days 
Plasma 
concentration-time 
curve of quercetin 
or kaempferol 
(Hollman 
et al., 
2001) 
10 mg/mL 
Single dose (500 
mL) 
1 day c) 
Endothelial 
function (FMD and 
NMD) 
(Lorenz et 
al., 2007) 
Green tea 6.67 mg/mL Single dose (300 1 day FRAP (Leenen et 
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a) Human pre-diabetic Mauritians; b) Basketball players during training; c) Postmenopausal women; FMD, flow-mediated dilatation; NMD, nitro-
mediated dilatation. 
mL) al., 2000) 
20 mg/mL 
Single dose (300 
mL) 
1 day TRAP 
(Serafini et 
al., 2000) 
16.67 mg/mL 
1st week (150 mL), 
2nd week (300 mL), 
3rd week 
(450mL)/day 
3 weeks TAS 
(Sung et 
al., 2000) 
3.33 mg/mL 
Eight doses (150 
mL)/ day, every 2h 
3 days 
Plasma 
concentration-time 
curve of quercetin 
or kaempferol 
(Hollman 
et al., 
2001) 
Vitaceae Vitis vinifera L. 
White wine 
dealcoholized 
20 mg/mL 
Single dose (300 
mL) 
1 day TRAP 
(Serafini et 
al., 2000) 
Red wine 
dealcoholized 
20 mg/mL 
Single dose (300 
mL) 
1 day TRAP 
(Serafini et 
al., 2000) 
Whole grapes 250 g 1 dose/day 4 weeks 
ORAC-PCA 
(Parker et 
al., 2007) 
Whole raisins 
50 g of golden 
raisins 
50 g sun dried-
raisins 
1 dose/day 4 weeks 
(Parker et 
al., 2007) 
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Table 3. Phenolic compounds with in vivo antioxidant activity evaluated in animal models. 
 
Tested compound Origin Time of exposure References 
Flavan-3 -ols    
(-)-Epicatechin Commercial 90 min (Hamauzu et al., 2006) 
Flavones 
Apiin Apium graveolens L. var. dulce (leaves) 28 days (P. Li et al., 2013) 
Flavonols 
Rutin Commercial 2 h (Sen et al., 2013) 
28 days (P. Li et al., 2013) 
2 h (Sen et al., 2014) 
Hydroxycinnamic acids 
5-caffeoylquinic acid Commercial 90 min (Hamauzu et al., 2006) 
Ferulic acid Corn bran 10 days (Z. Zhao et al., 2005) 
Commercial 14 days (Yeh & Yen, 2006) 
21 days (Fetoni et al., 2010) 
p-coumaric acid Corn bran 14 days (Yeh & Yen, 2006) 
10 days (Z. Zhao et al., 2005) 
Hydroxybenzoic acids 
Gallic acid Commercial 14 days (Yeh & Yen, 2006) 
Gentisic acid 14 days 
p-hydroxy-benzoic acid 14 days 
Protocatechuic acid Alpinia oxyphylla Miq. 9 days (Shi et al., 2006) 
Coumestans 
Pyrocatechol Commercial 1 day (Roche & Bogé, 2000) 
Anthocyanins 
Cyanidin 3-glucoside Abies koreana E.H.Wilson 2 weeks (Ramirez-Tortosa et al., 2001) 
Delphinidin 3-glucoside 
Malvidin 3-glucoside 
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Peonidin 3-glucoside 
Petunidin 3-glucoside 
Anthocyanin Ipomoea batatas (L.) Lam. 30 days (J. G. Zhao, Yan, Lu, & Zhang, 2013) 
Diferuloylmethanes 
Curcumin Commercial 6 weeks (Gao et al., 2013) 
31 days (Xie et al., 2014) 
Simple phenols 
Hydroquinone Commercial 1 day (Roche & Bogé, 2000) 
Phenol 
Resorcinol 
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Phenolic compounds 
Phenolic  
acids 
Flavonoids non-
anthocyanins 
Other phenolic 
compounds 
Lignans 
Enterolactone 
(RAE=24.1%) 
Sesamin 
(RAE=109.9%) 
Sesaminol 
(RAE=56.4%) 
 
Coumestans 
Coumestrol 
(RAE=9.8%) 
Catechol 
(RAE=19.4%) 
Flavanols 
Epigallocatechin 
gallate 
(RAE=43.1%) 
Flavanones 
Eriodictyol 
(RAE=40.8%) 
Hesperidin 
(RAE=22.9%) 
Naringenin 
(RAE=9.0%) 
Naringin 
(RAE=8.5%) 
Nobiletin 
(RAE=3.3%) 
Tangeretin 
(RAE=2.1%)) 
Flavanonols 
Taxifolin 
(RAE=30.7%) 
Hydroxybenzoic 
acids 
Ellagic acid 
(RAE=109.9%) 
Gallic acid 
(RAE=21.0%) 
Hydroxycinnamic 
acids 
Caffeic acid 
(RAE=40.2%), 60 
mg/mLa) 
Ferulic acid 
(RAE=17.2%) 
trans-Cinnamic acid 
(RAE=6.7%) 
Flavones 
Apigenin 
(RAE=35.3%) 
Flavonols 
Kaempferol 
(RAE=58.8%) 
Myricetin 
(RAE=7.2%) 
Quercetin 
(RAE=59.1%) 
Rutin 
(RAE=27.0%) 
Isoflavones/ 
isoflavanes 
Daidzein 
(RAE=10.3%) 
Equol 
(RAE=23.0%) 
Genistein 
(RAE=18.6%) 
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Figure 1. Phenolic compounds with in vivo antioxidant activity assessed in human healthy volunteers, during 1 h of exposure, expressed as RAE, 
carried out by Wang and Goodman (1999). a)Caffeic acid was isolated from Coffea spp. and tested during 2h in healthy human volunteers to 
evaluate its free and total phenolic content, through β-glucuronidase and alkaline hydrolysis procedures. 
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Figure 2. In vivo antioxidant activity of Vaccinium angustifolium Ait. (100 g of freeze-dried blueberries - equivalent to a 1.20 g of total 
anthocyanins) ingested by human healthy individuals. TEAC and ORAC assays were used to assess serum antioxidant status after 1 to 4h. The 
rate of absorption to the blood serum was also evaluated (Mazza et al., 2002). Results are expressed as mean values of the serum anthocyanins 
concentrations, 4h after ingestion of V. angustifolium. 
Vaccinium angustifolium Ait. 
anthocyanins 
Cyanidin Delphinidin Malvidin Peonidin Petunidin 
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Figure 3. The most important factors in the bioavailability and bio-efficacy of bioactive compounds. CYP450, Cytochrome 450 enzymes; 
COMT, Catechol-O-methyltransferases; SULT, Sulphotransferases; UDPGT, Uridine-5’-diphosphate glucuronosyl-transferases. 
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